Oral ingestion of the isoflavone genistein in STZ-induced diabetic rats, at a higher dosage (300 mg/kg/day) and for a longer period (24 weeks), restored the integrity of their myocardia, accompanied by reducing diabetes-induced cardiac inflammation and oxidative stress via the reduction of TNF-α, CRP and TGF-β1. Here, TNF is linked to diabetes mellitus.